OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
POAS$2.5755

Phaos Technology Holdings (Cayman) Limited

Advanced Medical Equipment & TechnologyVerified

Phaos Technology Holdings (Cayman) Limited has a market capitalization of SGD 35.23 million, with a market price of SGD 2.57 per share. The company has 13.71 million shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and return metrics are not available in the current dataset, and no industry-specific preferred metrics are provided for comparison. As a result, it is not possible to assess Phaos' performance relative to industry medians or to evaluate its return on invested capital (ROIC) or margin performance. Phaos' revenue concentration and geographic exposure are not disclosed in the available data. The company does not provide segment-level revenue breakdowns or geographic revenue distribution, making it difficult to assess the diversification of its business. Growth trajectory data is limited. The company's outlook for the current and next fiscal years is not quantified in the dataset, and no numeric deltas are provided to assess revenue or earnings growth expectations. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. Dilution risk is currently low, as there is no difference between basic and diluted shares outstanding. No adjustments have been applied to the valuation metrics, and no dilution sources are disclosed in the available documents. Recent events, including filings or transcripts, are not available in the dataset. The company's financial and operational disclosures are limited to basic share and valuation data, with no additional commentary or event-driven signals provided.

30-day price · POAS+0.50 (+24.4%)
Low$1.73High$2.59Close$2.55As of17 May, 00:00 UTC
Profile
CompanyPhaos Technology Holdings (Cayman) Limited
TickerPOAS.K
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Phaos Technology Holdings (Cayman) Limited is a company engaged in the development and provision of advanced medical equipment and technology, primarily serving the healthcare services and equipment sector.

Classification. Phaos is classified under the Healthcare economic sector, specifically in the Healthcare Services & Equipment business sector, with a high confidence level of 0.92.

Phaos Technology Holdings (Cayman) Limited has a market capitalization of SGD 35.23 million, with a market price of SGD 2.57 per share. The company has 13.71 million shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and return metrics are not available in the current dataset, and no industry-specific preferred metrics are provided for comparison. As a result, it is not possible to assess Phaos' performance relative to industry medians or to evaluate its return on invested capital (ROIC) or margin performance. Phaos' revenue concentration and geographic exposure are not disclosed in the available data. The company does not provide segment-level revenue breakdowns or geographic revenue distribution, making it difficult to assess the diversification of its business. Growth trajectory data is limited. The company's outlook for the current and next fiscal years is not quantified in the dataset, and no numeric deltas are provided to assess revenue or earnings growth expectations. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. Dilution risk is currently low, as there is no difference between basic and diluted shares outstanding. No adjustments have been applied to the valuation metrics, and no dilution sources are disclosed in the available documents. Recent events, including filings or transcripts, are not available in the dataset. The company's financial and operational disclosures are limited to basic share and valuation data, with no additional commentary or event-driven signals provided.
Key takeaways
  • Phaos Technology Holdings operates in the advanced medical equipment and technology sector with a market cap of SGD 35.23 million.
  • The company has no dilution between basic and diluted shares, indicating no immediate dilution risk.
  • Liquidity risk could not be assessed due to missing balance-sheet data and lack of going-concern language.
  • Revenue concentration, geographic exposure, and growth trajectory data are not disclosed in the available information.
  • The company's profitability and return metrics are not available for comparison with industry benchmarks.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySGD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3
FY-2
FY-1$0.00
FY0$167.7k-$5.3M-$5.1M-$5.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3
FY-2
FY-1
FY0$1.9M-$2.0M$129.6k
PeriodOCFCapExFCFSBC
FY-4
FY-3
FY-2
FY-1$0.00
FY0-$3.7M-$240.2k-$5.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2$3.0M$1.2M$231.7k
FQ-1
FQ0$1.9M-$2.0M$129.6k
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2$0.00
FQ-1
FQ0-$3.7M-$240.2k
Valuation
Market price$2.57
Market cap$35.2M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Advanced Medical Equipment & Technology · cohort 109 companies
MetricPOASActivity
Op margin-19.9% medp25 -150.5% · p75 8.7%
Net margin-18.4% medp25 -146.8% · p75 8.0%
Gross margin49.9% medp25 36.2% · p75 66.3%
R&D / revenue6.2% medp25 4.7% · p75 12.0%
CapEx / revenue-3.5% medp25 -7.8% · p75 -1.4%
Debt / equity14.5% medp25 0.9% · p75 54.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 23:55 UTC#e34c863d
Market quoteclose SGD 2.35 · shares 0.01B diluted
no public URL
2026-05-16 23:55 UTC#e6c20a09
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 00:43 UTCJob: d103c925